The Clinical Research and Trials Platform is one of the core platforms supporting research across the Unit's three thematic areas— Viral Pathogens, Vaccines, and Non-communicable diseases. It streamlines clinical research and trials while promoting excellence through capacity building.
About Us
For more than three decades the MRC/UVRI I & LSHTM Uganda Research Unit has generated evidence that underpins national, regional, and global responses to HIV and other pressing public‑health challenges. The Clinical Research and Trials Platform is the next step in that legacy: a central hub for designing, delivering and overseeing high-quality clinical trials.
Events
Our events span scientific symposia, community dialogues, and stakeholder engagements, providing a platform to share research, exchange ideas, and strengthen partnerships. We connect evidence with impact. Each event reflects our commitment to collaboration and informed action.
Our Services
From concept to close-out, our Clinical Research and Trials Platform provides comprehensive support to help research teams deliver high-quality, impactful studies. We work closely with investigators, sponsors, and regulatory authorities to ensure every trial is scientifically robust, ethically compliant, and operationally efficient.
Resources
Find documents and tools that support every stage of clinical research at the Platform. From protocol templates to training materials and SOPs, these resources are designed to help you plan, manage, and deliver high-quality clinical trials.
Publications
Our publications cover a broad spectrum of research, from clinical trials and observational studies to implementation science and social science, sharing evidence that informs health policy and practice
Knowledge Exchange
Knowledge Transfer & Exchange (KTE) is the Platform’s bridge between science and real‑world impact. We enable KTE by working with investigators to ensure research findings are effectively communicated to policy makers, practitioners, communities, and other stakeholders.
